The Department of Hematology stands as a premier discipline in Sichuan Province, serving as a clinical medicine undergraduate teaching unit at North Sichuan Medical College. Additionally, it functions as a training unit for postgraduate students practicing internal medicine, and responsible for the quality control of blood diseases management in Nanchong City. The department takes the lead in the Hematology Specialty Alliance at the Affiliated Hospital of North Sichuan Medical College.
At present, the in-patient department offers 98 beds, including 7 beds in the laminar flow ward, while the out-patient department provides services to patients with hematologic diseases, lymphoma, and additional services to VIPs. Our team consists of 16 professionals, including 5 physicians with doctoral degree, 2 with overseas education background, and 5 physicians are master's supervisors. The director of our department has international education background both in Japan and the United States, with advanced diagnostic and treatment skills, coupled with extensive clinical expertise in addressing blood disorders.
Equipped with advanced instruments such as the Fresenius apheresis system, flow cytometer, and RBC lifespan analyzer, the department excels in precise diagnoses across various aspects, including cell morphology, immunology, molecular biology, and cytogenetics, achieving advanced domestic standards. Annually, we provide healthcare services to thousands of patients with blood disorders from diverse regions, including routine services like chemotherapy, targeted therapy, autologous stem cell transplantation, allogeneic hematopoietic stem cell transplantation, CAR-T therapy, therapeutic apheresis, and plasma exchange.
Functioning as the diagnostic and treatment hub for challenging cases in Northeast Sichuan, the department is committed to consultations, referrals, and the training of grassroots physicians for challenging cases in the surrounding areas. Our diagnostic and therapeutic scope encompasses various common blood diseases, including anemia, acute and chronic leukemia, lymphomas, multiple myeloma, bone marrow failure, myeloproliferative neoplasms, myelodysplastic neoplasms, platelet disorders, hemophilia, and also rare blood diseases such as thrombotic thrombocytopenic purpura and hemophagocytic syndrome.